Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer

BACKGROUND AND PURPOSE: Treatment of intermediate and high-risk prostate cancer with a high BED has been shown to increase recurrence free survival (RFS). While high dose rate (HDR) brachytherapy, given as a boost is effective in delivering a high BED, many patients are not candidates for the proced...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Radiat Oncol
Hoofdauteurs: Anwar, Mekhail, Weinberg, Vivian, Seymour, Zachary, Hsu, I. Joe, Roach, Mack, Gottschalk, Alex R.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2016
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4721063/
https://ncbi.nlm.nih.gov/pubmed/26792201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-016-0585-y
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items